Literature DB >> 20109444

Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts.

Guo-qiang Cai1, Anni Zheng, Qingjiu Tang, Eric S White, Chu-Fang Chou, Candece L Gladson, Mitchell A Olman, Qiang Ding.   

Abstract

Fibroblast migration plays an important role in the normal wound healing process; however, dysregulated cell migration may contribute to the progressive formation of fibrotic lesions in the diseased condition. To examine the role of focal-adhesion-kinase (FAK)-related non-kinase (FRNK) in regulation of fibrotic lung fibroblast migration, we examined cell migration, FRNK expression, and activation of focal adhesion kinase (FAK) and Rho GTPase (Rho and Rac) in primary lung fibroblasts derived from both idiopathic pulmonary fibrosis (IPF) patients and normal human controls. Fibrotic (IPF) lung fibroblasts have increased cell migration when compared to control human lung fibroblasts. FRNK expression is significantly reduced in IPF lung fibroblasts, while activation of FAK, Rho and Rac is increased in IPF lung fibroblasts. Endogenous FRNK expression is inversely correlated with FAK activation and cell migration rate in IPF lung fibroblasts. Forced exogenous FRNK expression abrogates the increased cell migration, and blocked the activation of FAK and Rho GTPase (Rho and Rac), in IPF lung fibroblasts. These data for the first time provide evidence that downregulation of endogenous FRNK plays a role in promoting cell migration through FAK and Rho GTPase in fibrotic IPF lung fibroblasts. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109444      PMCID: PMC2871958          DOI: 10.1016/j.yexcr.2010.01.021

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  32 in total

Review 1.  Focal adhesion kinase: the first ten years.

Authors:  J Thomas Parsons
Journal:  J Cell Sci       Date:  2003-04-15       Impact factor: 5.285

2.  Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells.

Authors:  J M Taylor; C P Mack; K Nolan; C P Regan; G K Owens; J T Parsons
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  FAK integrates growth-factor and integrin signals to promote cell migration.

Authors:  D J Sieg; C R Hauck; D Ilic; C K Klingbeil; E Schaefer; C H Damsky; D D Schlaepfer
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

Review 4.  New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.

Authors:  Braden D Cox; Meera Natarajan; Michelle R Stettner; Candece L Gladson
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

5.  FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth.

Authors:  Christof R Hauck; Datsun A Hsia; Xose S Puente; David A Cheresh; David D Schlaepfer
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

6.  Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

Authors:  T E King; M I Schwarz; K Brown; J A Tooze; T V Colby; J A Waldron; A Flint; W Thurlbeck; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

7.  p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.

Authors:  Qiang Ding; J Robert Grammer; Mark A Nelson; Jun-Lin Guan; Jerry E Stewart; Candece L Gladson
Journal:  J Biol Chem       Date:  2004-11-19       Impact factor: 5.157

8.  Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin.

Authors:  Qiang Ding; Jerry Stewart; Charles W Prince; Pi-Ling Chang; Mohit Trikha; Xiaosi Han; J Robert Grammer; Candece L Gladson
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

9.  Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.

Authors:  Sha Zhu; Candece L Gladson; Kimberly E White; Qiang Ding; Jerry Stewart; Tong H Jin; Harold A Chapman; Mitchell A Olman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

10.  p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo.

Authors:  D Wang; J R Grammer; C S Cobbs; J E Stewart; Z Liu; R Rhoden; T P Hecker; Q Ding; C L Gladson
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  31 in total

1.  miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.

Authors:  Shanzhong Yang; Na Xie; Huachun Cui; Sami Banerjee; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2012-06-01       Impact factor: 5.191

2.  Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination.

Authors:  Shuqin Zhan; Guo-Qiang Cai; Anni Zheng; Yuping Wang; Jianping Jia; Haotian Fang; Youfeng Yang; Meng Hu; Qiang Ding
Journal:  Biochim Biophys Acta       Date:  2010-11-18

3.  Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.

Authors:  David M Habiel; Cory M Hogaboam
Journal:  Curr Pathobiol Rep       Date:  2017-05-02

4.  Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts.

Authors:  Hirokazu Urushiyama; Yasuhiro Terasaki; Shinya Nagasaka; Mika Terasaki; Shinobu Kunugi; Takahide Nagase; Yuh Fukuda; Akira Shimizu
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

5.  PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.

Authors:  Yan Geng; Xue Liu; Jiurong Liang; David M Habiel; Vrishika Kulur; Ana Lucia Coelho; Nan Deng; Ting Xie; Yizhou Wang; Ningshan Liu; Guanling Huang; Adrianne Kurkciyan; Zhenqiu Liu; Jie Tang; Cory M Hogaboam; Dianhua Jiang; Paul W Noble
Journal:  JCI Insight       Date:  2019-03-21

Review 6.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

7.  Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-β.

Authors:  Qiang Ding; Indhu Subramanian; Tracy R Luckhardt; Pulin Che; Meghna Waghray; Xue-Ke Zhao; Nathaniel Bone; Ashish R Kurundkar; Louise Hecker; Meng Hu; Yong Zhou; Jeffrey C Horowitz; Ragini Vittal; Victor J Thannickal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-30       Impact factor: 5.464

8.  FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.

Authors:  Qiang Ding; Guo-Qiang Cai; Meng Hu; Youfeng Yang; Anni Zheng; Qinjiu Tang; Candece L Gladson; Haurko Hayasaka; Hongju Wu; Zhiying You; Brian D Southern; Lisa M Grove; S Ohidar Rahaman; Haotian Fang; Mitchell A Olman
Journal:  Am J Pathol       Date:  2013-03-14       Impact factor: 4.307

9.  Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of α-smooth muscle actin filaments during myofibroblast differentiation.

Authors:  Guo-Qiang Cai; Chu-Fang Chou; Meng Hu; Anni Zheng; Louis F Reichardt; Jun-Lin Guan; Haotian Fang; Tracy R Luckhardt; Yong Zhou; Victor J Thannickal; Qiang Ding
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-10       Impact factor: 5.464

10.  The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.

Authors:  Ying Meng; Ting Li; Gao-Su Zhou; Yan Chen; Chang-Hui Yu; Miao-Xia Pang; Wei Li; Yang Li; Wen-Yong Zhang; Xu Li
Journal:  Antioxid Redox Signal       Date:  2014-10-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.